Literature DB >> 21093719

Frailty defined by deficit accumulation and geriatric medicine defined by frailty.

Kenneth Rockwood1, Arnold Mitnitski.   

Abstract

As nonreplicative cells age, they commonly accumulate subcellular deficits that can compromise function. As people age, they too experience problems that can accumulate. As deficits (symptoms, signs, illnesses, disabilities) accumulate, people become more susceptible to adverse health outcomes, including worse health and even death. This state of increased risk of adverse health outcomes is indistinguishable from the idea of frailty, so deficit accumulation represents another way to define frailty. Counting deficits not only allows grades of frailty to be discerned but also provides insights into the complex problems of older adults. This process is potentially useful to geriatricians who need to be experts in managing complexity. A key to managing complexity is through instruments such as a comprehensive geriatric assessment, which can serve as the basis for routine clinical estimation of an individual's degree of frailty. Understanding people and their needs as deficits accumulate is an exciting challenge for clinical research on frailty and its management by geriatricians.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21093719     DOI: 10.1016/j.cger.2010.08.008

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  253 in total

1.  The frailty index in Europeans: association with age and mortality.

Authors:  Roman Romero-Ortuno; Rose Anne Kenny
Journal:  Age Ageing       Date:  2012-04-19       Impact factor: 10.668

2.  Successful aging as a continuum of functional independence: lessons from physical disability models of aging.

Authors:  Kristin A Lowry; Abbe N Vallejo; Stephanie A Studenski
Journal:  Aging Dis       Date:  2011-08-15       Impact factor: 6.745

Review 3.  Frailty Clinical Phenotype: A Physical and Cognitive Point of View.

Authors:  Mylene Aubertin-Leheudre; Adam J Woods; Stephen Anton; Ronald Cohen; Marco Pahor
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2015-10-20

4.  Association between a Deficit Accumulation Frailty Index and Mobility Outcomes in Older Adults: Secondary Analysis of the Lifestyle Interventions and Independence for Elders (LIFE) Study.

Authors:  Joshua D Brown; Golnoosh Alipour-Haris; Marco Pahor; Todd M Manini
Journal:  J Clin Med       Date:  2020-11-22       Impact factor: 4.241

Review 5.  Frailty in Hematologic Malignancy.

Authors:  Thuy T Koll; Ashley E Rosko
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

6.  The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.

Authors:  Claire Johnston; Sarah N Hilmer; Andrew J McLachlan; Slade T Matthews; Peter R Carroll; Carl M Kirkpatrick
Journal:  Eur J Clin Pharmacol       Date:  2014-02-14       Impact factor: 2.953

7.  Comparison between frailty index of deficit accumulation and fracture risk assessment tool (FRAX) in prediction of risk of fractures.

Authors:  Guowei Li; Lehana Thabane; Alexandra Papaioannou; Jonathan D Adachi
Journal:  Bone       Date:  2015-04-25       Impact factor: 4.398

8.  Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012.

Authors:  G Berrut; S Andrieu; I Araujo de Carvalho; J P Baeyens; H Bergman; B Cassim; F Cerreta; M Cesari; H B Cha; L K Chen; A Cherubini; M Y Chou; A J Cruz-Jentoft; L De Decker; P Du; B Forette; F Forette; A Franco; R Guimaraes; L M Guttierrez-Robledo; J Jauregui; V Khavinson; W J Lee; L N Peng; C Perret-Guillaume; M Petrovic; F Retornaz; K Rockwood; L Rodriguez-Manas; C Sieber; G Spatharakis; O Theou; E Topinkova; B Vellas; A Benetos
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

9.  Identifying and Implementing Endpoints for Geriatric Mice.

Authors:  Linda A Toth
Journal:  Comp Med       Date:  2018-11-28       Impact factor: 0.982

Review 10.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.